3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
4
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Leukemia, Myeloid, Acute
44
Precursor Cell Lymphoblastic Leukemia-Lymphoma
30
Myelodysplastic Syndromes
26
Hematologic Neoplasms
20
Lymphoma, Non-Hodgkin
19
Multiple Myeloma
18
Lymphoma
18
Recurrence
15
Lymphoma, B-Cell
14
Lymphoma, Large B-Cell, Diffuse
13
Leukemia, Lymphocytic, Chronic, B-Cell
12
Burkitt Lymphoma
12
Breast Neoplasms
11
Pancreatic Neoplasms
10
Ovarian Neoplasms
10
Lymphoma, Follicular
10
Neoplasm Metastasis
9
Melanoma
9
Leukemia, Myelomonocytic, Chronic
9
Myeloproliferative Disorders
8
Lymphoma, Mantle-Cell
7
Lymphoma, B-Cell, Marginal Zone
7
Leukemia, Biphenotypic, Acute
7
Leukemia
7
Hodgkin Disease
7
Glioblastoma
7
Carcinoma, Non-Small-Cell Lung
7
Triple Negative Breast Neoplasms
6
Stomach Neoplasms
6
Osteosarcoma
6
Interventions
ponatinib
2
fludarabine phosphate
2
Cyclophosphamide
2
Busulfan
2
pegylated granulocyte colony-stimulating factor
1
merphos
1
letermovir
1
fludarabine
1
blinatumomab
1
Whole-Body Irradiation
1
Stem Cell Transplantation
1
Specimen Handling
1
Rituximab
1
Positron-Emission Tomography
1
N,N-dicyclohexyl-isoborneol-10-sulfonamide
1
Methotrexate
1
Melphalan
1
Cytarabine
1
Cord Blood Stem Cell Transplantation
1
Clofarabine
1
CT-P10
1
Bone Marrow Purging
1
Blood Component Removal
1
Antilymphocyte Serum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Leukemia, Myeloid, Accelerated Phase
×
fludarabine
×
Clear all
NCT06802315
2025-06-25
BMT-13
University of Illinois at Chicago
Phase 2
Recruiting
38 enrolled